Synthesis, chaperoning, and metabolism of proteins are regulated by IMT-3/TrkC signaling in the medulloblastoma cell line daoy

Journal of Proteome Research

Volumn 7, Issue 5, 2008, Pages 1932-1944

  Gruber Olipitz, Mariella ^a   Ströbel, Thomas ^b   Chen, Wei Qiang ^a   Grotzer, Michael A ^c   Quehenberger, Franz ^d   Slave, Irene ^a   Lubec, Gert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

2d gel electrophoresis; C; MALDI TOF TOF; Medulloblastoma; Neurotrophin 3; Protein machinery; Trk

Indexed keywords

CHAPERONE; NEUROTROPHIN 3; NEUROTROPHIN 3 RECEPTOR; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDULLOBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN METABOLISM; PROTEIN PROCESSING; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; RNA SPLICING; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TWO DIMENSIONAL GEL ELECTROPHORESIS; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CHILD; ENZYME ACTIVATION; GENETICS; MASS SPECTROMETRY; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CHILD; ENZYME ACTIVATION; HUMANS; MEDULLOBLASTOMA; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEUROTROPHIN 3; PROGNOSIS; RECEPTOR, TRKC; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 52049118591     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr700724a     Document Type: Article

References (66)

1. Grotzer, M. A.; Janss, A. J.; Fung, K.; Biegel, J. A.; Sutton, L. N.; Rorke, L. B.; Zhao, H.; Cnaan, A.; Phillips, P. C.; Lee, V. M.; Trojanowski, J. Q. TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J. Clin. Oncol. 2000, 18, 1027-1035.
2. Washiyama, K.; Muragaki, Y.; Rorke, L. B.; Lee, V. M.; Feinstein, S. G; Radeke, M. J.; Blumberg, D.; Kaplan, D. R.; Trojanowski, J. Q. Neurotrophin and neurotrophin receptor proteins in medullo-blastomas and other primitive neuroectodermal tumors of the pediatric central nervous system. Am. J. Pathol. 1996, 748, 929-940.
3. Calkhoven, C. F.; Muller, C.; Leutz, A. Translational control of gene expression and disease. Trends Mol. Med. 2002, 8, 577-583.
4. Ruggero, D.; Pandolfi, P. P. Does the ribosome translate cancer. Nat. Rev. Cancer 2003, 3, 179-192.
5. Kalnina, Z.; Zayakin, P.; Silina, K.; Line, A. Alterations of pre-mRNA splicing in cancer. Genes, Chromosomes Cancer 2005, 42, 342-357.
6. Clemens, M. J. Targets and mechanisms for the regulation of translation in malignant transformation. Oncogene 2004, 23, 3180-3188.
7. Audic, Y.; Hartley, R. S. Post-transcriptional regulation in cancer. Biol. Cell. 2004, 96, 479-498.
8. Whitesell, L.; Lindquist, S. L. HSP90 and the chaperoning of cancer. Nat. Rev. Cancer 2005, 5, 761-772.
9. Voutsadakis, I. A. Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2. J. Cell. Mol. Med. 2007, 11, 252-285.
10. Lah, T. T.; Duran Alonso, M. B.; Van Noorden, C. J. Antiprotease therapy in cancer: hot or not. Expert Opin. Biol. Ther. 2006, 6, 257-279.
11. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
12. John, J. P.; Chen, W. Q.; Pollak, A.; Lubec, G. Mass spectrometric studies on mouse hippocampal synapsins la, Ila, and lib and identification of a novel phosphorylation site at serine-546. J. Proteome Res. 2007, 6, 2695-2710.
13. Langen, H.; Berndt, P.; Roder, D.; Cairns, N.; Lubec, G.; Fountou-lakis, M. Two-dimensional map of human brain proteins. Electrophoresis 1999, 20, 907-916.
14. Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc., Ser. B 1995, 57, 289-300.
15. Ardini, E.; Pesole, G.; Tagliabue, E.; Magnifico, A.; Castronovo, V.; Sobel, M. E.; Colnaghi, M. I.; Menard, S. The 67-kDa laminin receptor originated from a ribosomal protein that acquired a dual function during evolution. Mol. Biol. Evol. 1998, 15, 1017-1025.
16. Givant-Horwitz, V.; Davidson, B.; Reich, R. Laminin-induced signaling in tumor cells. Cancer Lett. 2005, 223, 1-10.
17. Shi, Y.; Zhai, H.; Wang, X.; Wu, H.; Ning, X.; Han, Y.; Zhang, D.; Xiao, B.; Wu, K.; Fan, D. Multidrug-resistance-associated protein MGrl-Ag is identical to the human 37-kDa laminin receptor precursor. Cell. Mol. Life Sci. 2002, 59, 1577-1583.
18. Streit, M.; Schmidt, R.; Hilgenfeld, R. U.; Thiel, E.; Kreuser, E. D. Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors. Recent Results Cancer Res. 1996, 142, 19-50.
19. Honore, B.; Baandrup, U.; Vorum, H. Heterogeneous nuclear ribonucleoproteins F and H/H' show differential expression in normal and selected cancer tissues. Exp. Cell Res. 2004, 294, 199-209.
20. Rauch, J.; Ahlemann, M.; Schaffrik, M.; Mack, B.; Ertongur, S.; Andratschke, M.; Zeidler, R.; Lang, S.; Gires, O. Allogenic antibody-mediated identification of head and neck cancer antigens. Biochem. Biophys. Res. Commun. 2004, 323, 156-162.
21. Garneau, D.; Revil, T.; Fisette, J. F.; Chabot, B. Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x. J. Biol. Chem. 2005, 280, 22641-22650.
22. Sturla, L. M.; Cowan, C. W.; Guenther, L.; Castellino, R. C; Kim, I. Y.; Pomeroy, S. L. A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death. Cancer Res. 2005, 65, 5683-5689.
23. Tu, L. C.; Yan, X.; Hood, L.; Lin, B. Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells. Mol. Cell. Proteomics 2007, 6, 575-588.
24. Hatton, B. A.; Knoepfler, P. S.; Kenney, A. M.; Rowitch, D. H.; de Alboran, I. M.; Olson, J. M.; Eisenman, R. N. N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth. Cancer Res. 2006, 66, 8655-8661.
25. Mikula, M.; Dzwonek, A.; Karczmarski, J.; Rubel, T.; Dadlez, M.; Wyrwicz, L. S.; Bomsztyk, K.; Ostrowski, J. Landscape of the hnRNP K protein-protein interactome. Proteomics 2006, 6, 2395-2406.
26. Lynch, M.; Chen, L.; Ravitz, M. J.; Mehtani, S.; Korenblat, K.; Pazin, M. J.; Schmidt, E. V. hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation. Mol. Cell. Biol. 2005, 25, 6436-6453.
27. Ostareck-Lederer, A.; Ostareck, D. H. Control of mRNA translation and stability in haematopoietic cells: the function of hnRNPs K and E1/E2. Biol. Cell. 2004, 96, 407-411.
28. Notari, M.; Neviani, P.; Santhanam, R.; Blaser, B. W.; Chang, J. S.; Galietta, A.; Willis, A. E.; Roy, D. C.; Caligiuri, M. A.; Marcucci, G.; Perrotti, D. A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation. Blood 2006, 107, 2507-2516.
29. Mandal, M.; Vadlamudi, R.; Nguyen, D.; Wang, R. A.; Costa, L.; Bagheri-Yarmand, R.; Mendelsohn, J.; Kumar, R. Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function. J. Biol. Chem. 2001, 276, 9699-9704.
30. Zhang, P.; Li, H.; Wu, M. L.; Chen, X. Y.; Kong, Q. Y.; Wang, X. W.: Sun, Y.; Wen, S.; Liu, J. c-Myc downregulation: a critical molecular event in resveratrol-induced cell cycle arrest and apoptosis of human medulloblastoma cells. J. Neurooncol. 2006, 80, 123-131.
31. Gevaert, K.; Goethals, M.; Martens, L.; Van Damme, J.; Staes, A.; Thomas, G. R.; Vandekerckhove, J. Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat. Biotechnol. 2003, 21, 566-569.
32. Polevoda, B.; Sherman, F. N-terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins. J. Mol. Biol. 2003, 325, 595-622.
33. Richter, N. J.; Rogers, G. W., Jr.; Hensold, J. O.; Merrick, W. C. Further biochemical and kinetic characterization of human eukaryotic initiation factor 4H. J. Biol. Chem. 1999, 274, 35415-35424.
34. Bordeleau, M. E.; Matthews, J.; Wojnar, J. M.; Lindqvist, L.; Novae, O.; Jankowsky, E.; Sonenberg, N.; Northcote, P.; Teesdale-Spittle, P.; Pelletier, J. Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 10460-10465.
35. Wade, C.; Shea, K. A.; Jensen, R. V.; McAlear, M. A. EBP2 is a member of the yeast RRB regulon, a transcriptionally coregulated set of genes that are required for ribosome and rRNA biosynthesis. Mol. Cell. Biol. 2001, 21, 8638-8650.
36. Tsujii, R.; Miyoshi, K.; Tsuno, A.; Matsui, Y.; Toh-e, A.; Miyakawa, T.; Mizuta, K. Ebp2p, yeast homologue of a human protein that interacts with Epstein-Barr virus nuclear antigen 1, is required for pre-rRNA processing and ribosomal subunit assembly. Genes Cells 2000, 5, 543-553.
37. Ionescu, C. N.; Origanti, S.; McAlear, M, A. The yeast rRNA biosynthesis factor Ebp2p is also required for efficient nuclear division. Yeast 2004, 21, 1219-1232.
38. Pilarsky, C.; Wenzig, M.; Specht, T.; Saeger, H. D.; Grutzmann, R. Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia 2004, 6, 744-750.
39. Strausberg, R. L.; Feingold, E. A.; Grouse, L. H.; Derge, J. G.; Klausner, R. D.; Collins, F. S.; Wagner, L.; Shenmen, C. M.; Schuler, G. D.; Altschul, S. F.; Zeeberg, B.; Buetow, K. H.; Schaefer, C. F.; Bhat, N. K.; Hopkins, R. F.; Jordan, H.; Moore, T.; Max, S. I.; Wang, J.; Hsieh, F.; Diatchenko, L.; Marusina, K.; Farmer, A. A.; Rubin, G. M.; Hong, L.; Stapleton, M.; Soares, M. B.; Bonaldo, M. F.; Casavant, T. L.; Scheetz, T. E.; Brownstein, M. J.; Usdin, T. B.; Toshiyuki, S.; Carninci, P.; Prange, C.; Raha, S. S.; Loquellano, N. A.; Peters, G. J.; Abramson, R. D.; Mullahy, S. J.; Bosak, S. A.; McEwan, P. J.; McKernan, K. J.; Malek, J. A.; Gunaratne, P. H.; Richards, S.; Worley, K. C; Hale, S.; Garcia, A. M.; Gay, L. J.; Hulyk, S. W.; Villalon, D. K.; Muzny, D. M.; Sodergren, E. J.; Lu, X.; Gibbs, R. A.; Fahey, J.; Helton, E.; Ketteman, M.; Madan, A.; Rodrigues, S.; Sanchez, A.; Whiting, M.; Young, A. C; Shevchenko, Y.; Bouffard, G. G.; Blakesley, R. W.; Touchman, J. W.; Green, E. D.; Dickson, M. C.; Rodriguez, A. C.; Grimwood, J.; Schmutz, J.; Myers, R. M.; Butterfield, Y. S.; Krzywinski, M. I.; Skalska, U.; Smailus, D. E.; Schnerch, A.; Schein, J. E.; Jones, S. J.; Marra, M. A. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 16899-16903.
40. Maeda, T.; Furukawa, S. Transformation-associated changes in gene expression of alternative splicing regulatory factors in mouse fibroblast cells. Oncol. Rep. 2001, 8, 563-566.
41. Cracchiolo, B. M.; Heller, D. S.; Clement, P. M.; Wolff, E. C.; Park, M. H.; Hanauske-Abel, H. M. Eukaryotic initiation factor 5A-1 (eIF5A-l) as a diagnostic marker for aberrant proliferation in intraepithelial neoplasia of the vulva. Gynecol. Oncol. 2004, 94, 217-222.
42. Nishimura, K.; Murozumi, K.; Shirahata, A.; Park, M. H.; Kashiwagi, K.; Igarashi, K. Independent roles of eIF5A and polyamines in cell proliferation. Biochem. J. 2005, 385, 779-785.
43. Li, A. L.; Li, H. Y.; Jin, B. F.; Ye, Q. N.; Zhou, T.; Yu, X. D.; Pan, X.; Man, J. H.; He, K.; Yu, M.; Hu, M. R.; Wang, J.; Yang, S. C.; Shen, B. F.; Zhang, X. M. A novel eIF5A complex functions as a regulator of p53 and p53-dependent apoptosis. J. Biol. Chem. 2004, 279, 49251-49258.
44. Taylor, C. A.; Sun, Z.; Cliche, D. O.; Ming, H.; Eshaque, B.; Jin, S.; Hopkins, M. T.; Thai, B.; Thompson, J. E. Eukaryotic translation initiation factor 5A induces apoptosis in colon cancer cells and associates with the nucleus in response to tumour necrosis factor alpha signalling. Exp. Cell. Res. 2007, 313, 437-449.
45. Jin, B. F.; He, K.; Wang, H. X; Wang, J.; Zhou, T.; Lan, Y.; Hu, M. R.; Wei, K. H.; Yang, S. C.; Shen, B. F.; Zhang, X. M. Proteomic analysis of ubiquitin-proteasome effects: insight into the function of eukaryotic initiation factor 5A. Oncogene 2003, 22, 4819-4830.
46. Jao, D. L.; Chen, K. Y. Tandem affinity purification revealed the hypusine-dependent binding of eukaryotic initiation factor 5A to the translating 80S ribosomal complex. J. Cell Biochem. 2006, 97, 583-598.
47. Nousiainen, M.; Sillje, H. H.; Sauer, G.; Nigg, E. A.; Korner, R. Phosphoproteome analysis of the human mitotic spindle. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 5391-5396.
48. Hino, M.; Kurogi, K.; Okubo, M. A.; Murata-Hori, M.; Hosoya, H. Small heat shock protein 27 (HSP27) associates with tubulin/ microtubules in HeLa cells. Biochem. Biophys. Res. Commun. 2000, 271, 164-169.
49. Chao, X.; Muff, T. J.; Park, S. Y.; Zhang, S.; Pollard, A. M.; Ordal, G. W.; Bilwes, A. M.; Crane, B. R. A receptor-modifying deamidase in complex with a signaling phosphatase reveals reciprocal regulation. Cell 2006, 124, 561-571.
50. Ciocca, D. R.; Calderwood, S. K. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005, 10, 86-103.
51. Morino, M.; Tsuzuki, T.; Ishikawa, Y.; Shirakami, T.; Yoshimura, M.; Kiyosuke, Y.; Matsunaga, K.; Yoshikumi, C.; Saijo, N. Specific expression of HSP27 in human tumor cell lines in vitro. In Vivo 1997, 11, 179-184.
52. Wang, X.; Qin, Z. H.; Leng, Y.; Wang, Y.; Jin, X.; Chase, T. N.; Bennett, M. C. Prostaglandin Al inhibits rotenone-induced apoptosis in SH-SY5Y cells. J. Neurochem. 2002, 83, 1094-1102.
53. Miyazaki, T.; Kato, H.; Faried, A.; Sohda, M.; Nakajima, M.; Fukai, Y.; Masuda, N.; Manda, R.; Fukuchi, M.; Ojima, H.; Tsukada, K.; Kuwano, H. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma. Anticancer Res. 2005, 25, 2749-2755.
54. Huang, Q.; Zu, Y.; Fu, X.; Wu, T. Expression of heat shock protein 70 and 27 in non-small cell lung cancer and its clinical significance. J. Huazhong Univ. Sci. Technol. Med. Sci. 2005, 25, 693-695.
55. Luk, J. M.; Lam, C. T.; Siu, A. F.; Lam, B. Y.; Ng, I. O.; Hu, M. Y.; Che, C. M.; Fan, S. T. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics 2006, 6, 1049-1057.
56. Ungar, D. R.; Hailat, N.; Strahler, J. R.; Kuick, R. D.; Brodeur, G. M.; Seeger, R. C; Reynolds, C. P.; Hanash, S. M. Hsp27 expression in neuroblastoma: correlation with disease stage. J. Natl. Cancer Inst. 1994, 86, 780-784.
57. Neirynck, K.; Waterschoot, D.; Vandekerckhove, J.; Ampe, C.; Rommelaere, H. Actin interacts with CCT via discrete binding sites: a binding transition-release model for CCT-mediated Actin folding. J. Mol. Biol. 2006, 355, 124-138.
58. Sevigny, G.; Joly, E. C; Bibor-Hardy, V.; Lemieux, N. Assignment of the human homologue of the mTRiC-P5 gene (TRIC5) to band lq23 by fluorescence in situ hybridization. Genomics 1994, 22, 634-636.
59. Midorikawa, Y.; Tsutsumi, S.; Taniguchi, H.; Ishii, M.; Kobune, Y.; Kodama, T.; Makuuchi, M.; Aburatani, H. Identification of genes associated with dedifferentiation of hepatocellular carcinoma with expression profiling analysis. Jpn. J. Cancer. Res. 2002, 93, 636-643.
60. Wong, N.; Chan, A.; Lee, S. W.; Lam, E.; To, K. F.; Lai, P. B.; Li, X. N.; Liew, C. T.; Johnson, P. J. Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression, J. Hepatol. 2003, 38, 298-306.
61. Peters, D. G.; Kudla, D. M.; Deloia, J. A.; Chu, T. J.; Fairfull, L.; Edwards, R. P.; Ferrell, R. E. Comparative gene expression analysis of ovarian carcinoma and normal ovarian epithelium by serial analysis of gene expression. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 1717-1723.
62. Afjehi-Sadat, L.; Gruber-Olipitz, M.; Felizardo, M.; Slave, I.; Lubec, G. Expression of proteasomal proteins in ten different tumor cell lines. Amino Acids 2004, 27, 129-140.
63. Li, D. Q.; Wang, L.; Fei, F.; Hou, Y. F.; Luo, J. M.; Zeng, R.; Wu, J.; Lu, J. S.; Di, G. H.; Ou, Z. L.; Xia, Q. C.; Shen, Z. Z.; Shao, Z. M. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry. Proteomics 2006, 6, 3352-3368.
64. Liu, Y.; Liu, H.; Han, B.; Zhang, J. T. Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis. Cancer Res. 2006, 66, 3248-3255.
65. Liaudet-Coopman, E.; Beaujouin, M.; Derocq, D.; Garcia, M.; Glondu-Lassis, M.; Laurent-Matha, V.; Prebois, C.; Rochefort, H.; Vignon, F. Cathepsin D: newly discovered functions of a longstanding aspartic protease in cancer and apoptosis. Cancer Lett. 2006, 237, 167-179.
66. Beaujouin, M.; Baghdiguian, S.; Glondu-Lassis, M; Berchem, G.; Liaudet-Coopman, E. Overexpression of both catalytically active and -inactive cathepsin D by cancer cells enhances apoptosis-dependent chemo-sensitivity. Oncogene 2006, 25, 1967-1973.